Physician

Brian P Engebrecht, MD

According to 2025 Medicare claims, Brian Engebrecht, MD (NPI: 1629040191) practices urology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION (NPI: 1366425274; TIN: 421411630) and primary practice location at 61265-6812. Engebrecht is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799), UnityPoint Accountable Care, L.C. (ACO ID: A5170), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Engebrecht's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 674 traditional Medicare patients, billed 10,255 HCPCS/CPT codes, and received $187,013 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,359 prescription claims across 930 beneficiaries totaling $1,387,333 in drug costs, led by Xtandi (Enzalutamide). DME data shows 164 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $309,140 to $187,013. In contrast, Part D prescription costs have moved sharply higher in recent years, from $366,722 to $1,387,333. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $424 and ending at $695.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	926	15,563	$309,140
2016	825	12,753	$241,016
2017	938	16,373	$288,061
2018	1,074	15,453	$331,186
2019	923	9,749	$211,387
2020	851	10,524	$205,132
2021	844	16,698	$271,103
2022	806	17,323	$260,260
2023	745	13,383	$205,410
2024	674	10,255	$187,013

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	610	4,039	$366,722
2016	593	3,821	$330,198
2017	606	4,134	$351,683
2018	656	4,224	$482,050
2019	670	4,066	$445,816
2020	779	4,471	$525,613
2021	908	4,939	$696,044
2022	885	4,978	$755,131
2023	866	4,802	$1,495,782
2024	930	5,359	$1,387,333

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	93	$8,941
2016	13	213	$25,581
2017	N/R	152	$21,715
2018	12	177	$30,227
2019	N/R	214	$43,388
2020	N/R	160	$38,596
2021	13	201	$50,985
2022	11	187	$49,667
2023	N/R	171	$41,797
2024	11	164	$44,302

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	239	346	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	520	708	$58
51798	Ultrasound measurement of bladder capacity after voiding	262	345	$8
81000	Manual urinalysis test with examination using microscope, non-automated	80	81	$4
81001	Manual urinalysis test with examination using microscope, automated	558	934	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	61	1,950	$791,603
Myrbetriq	Mirabegron	236	10,500	$157,961
Gemtesa	Vibegron	98	5,118	$80,772
Tamsulosin Hcl	Tamsulosin Hcl	1,448	94,784	$24,558
Abiraterone Acetate	Abiraterone Acetate	12	360	$19,752

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	38	$23,879
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	11	72	$19,728
A4332	Lubricant, individual sterile packet, each	N	N/R	54	$695

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Brian P. Engebrecht, MD?

Tedicare shows public-source Medicare data for Brian P. Engebrecht, MD (NPI 1629040191), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian P. Engebrecht, MD have ACO affiliation data?

Brian P. Engebrecht, MD is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), UnityPoint Accountable Care, L.C. (MSSP, ACO ID A5170), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Brian P. Engebrecht, MD?

Brian P. Engebrecht, MD is linked to IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION (billing NPI 1366425274) in the available physician profile data.

Does Brian P. Engebrecht, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.